Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,008 | 414 | 99.2% |
| Education | $76.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,129 | 149 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,264 | 50 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $1,078 | 36 | $0 (2024) |
| United Therapeutics Corporation | $596.87 | 14 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $502.79 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $397.19 | 18 | $0 (2024) |
| GENZYME CORPORATION | $309.25 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $296.29 | 17 | $0 (2023) |
| Genentech USA, Inc. | $267.59 | 17 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $246.82 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,101 | 48 | GlaxoSmithKline, LLC. ($515.19) |
| 2023 | $1,473 | 64 | GlaxoSmithKline, LLC. ($583.04) |
| 2022 | $1,532 | 71 | GlaxoSmithKline, LLC. ($552.33) |
| 2021 | $1,582 | 73 | GlaxoSmithKline, LLC. ($470.10) |
| 2020 | $615.51 | 34 | GlaxoSmithKline, LLC. ($241.13) |
| 2019 | $1,489 | 61 | GlaxoSmithKline, LLC. ($501.54) |
| 2018 | $1,872 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($673.39) |
| 2017 | $421.39 | 12 | Actelion Pharmaceuticals US, Inc. ($106.48) |
All Payment Transactions
415 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: Immunology | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $63.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.07 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 768 | 942 | $153,118 | $54,800 |
| 2022 | 14 | 1,054 | 1,315 | $197,016 | $74,780 |
| 2021 | 16 | 1,345 | 1,756 | $308,307 | $113,309 |
| 2020 | 15 | 1,087 | 1,548 | $344,108 | $126,383 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 89 | $45,615 | $14,446 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 76 | 116 | $17,278 | $7,938 | 45.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 85 | $19,660 | $7,552 | 38.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 118 | $18,276 | $7,012 | 38.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 48 | $18,745 | $6,177 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 59 | 75 | $6,338 | $3,174 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 33 | 33 | $8,739 | $3,058 | 35.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,950 | $1,577 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 13 | $2,775 | $1,301 | 46.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 94 | 94 | $3,388 | $746.04 | 22.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 105 | 106 | $2,827 | $605.65 | 21.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 74 | 74 | $2,538 | $500.12 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 17 | 17 | $701.00 | $431.09 | 61.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 52 | 56 | $1,288 | $283.36 | 22.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 102 | $52,122 | $17,037 | 32.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 90 | 180 | $34,740 | $14,067 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 203 | $27,202 | $10,894 | 40.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 65 | 69 | $25,944 | $10,235 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 84 | 127 | $19,568 | $9,160 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 72 | 79 | $7,426 | $3,982 | 53.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 35 | 35 | $9,155 | $3,554 | 38.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $4,864 | $1,850 | 38.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 142 | 142 | $5,254 | $1,278 | 24.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 156 | 156 | $4,212 | $1,039 | 24.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 95 | 95 | $3,515 | $705.19 | 20.1% |
About Dr. Kenneth Leung, M.D
Dr. Kenneth Leung, M.D is a Internal Medicine healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1518306471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Leung, M.D has received a total of $10,085 in payments from pharmaceutical and medical device companies, with $1,101 received in 2024. These payments were reported across 415 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,008).
As a Medicare-enrolled provider, Leung has provided services to 4,254 Medicare beneficiaries, totaling 5,561 services with total Medicare billing of $369,272. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Ashland, KY
- Active Since 06/24/2013
- Last Updated 11/30/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518306471
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,866
- NUCALA (Biological) $1,040
- UPTRAVI (Drug) $843.99
- SPIRIVA RESPIMAT (Drug) $603.89
- TYVASO (Drug) $384.67
- XOLAIR (Drug) $269.42
- Xolair (Biological) $236.72
- XOLAIR (Biological) $233.37
- ACTHAR (Biological) $228.49
- GLASSIA (Biological) $223.81
- OFEV (Drug) $220.09
- DUPIXENT (Biological) $218.84
- TEZSPIRE (Biological) $179.20
- CardioMEMS HF System (Device) $170.44
- TUDORZA PRESSAIR (Drug) $157.82
- XARELTO (Drug) $146.55
- BEVYXXA (Drug) $136.75
- DUPIXENT (Drug) $132.47
- LONHALA MAGNAIR (Drug) $131.75
- FASENRA (Biological) $120.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ashland
Dr. Basel Edris, Md, MD
Internal Medicine — Payments: $42,620
Dr. Mehrdad Tavallaee, Md, MD
Internal Medicine — Payments: $6,878
Diane Settles, Md, MD
Internal Medicine — Payments: $6,278
Alexandr Karimov, M.d, M.D
Internal Medicine — Payments: $5,982
Roger Klein, M.d, M.D
Internal Medicine — Payments: $5,835
Dr. Traci Sanchez-Vanhoose, M.d, M.D
Internal Medicine — Payments: $5,453